Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionActivation receptor-induced tolerance of mature NK cells in vivo requires signaling through the receptor and is reversibleRegulation of immune cell function and differentiation by the NKG2D receptorResistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cellsNewtonian cell interactions shape natural killer cell educationNKG2D ligands as therapeutic targetsBACL is a novel brain-associated, non-NKC-encoded mammalian C-type lectin-like receptor of the CLEC2 familyTransfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activationPerturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.ER stress affects processing of MHC class I-associated peptides.Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G.Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cellsIntact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1Activation of naive NK cells in response to Listeria monocytogenes requires IL-18 and contact with infected dendritic cellsInterleukin 10 decreases MICA expression on melanoma cell surface.NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational studyRegulation of ligands for the NKG2D activating receptor.Oncogenic stress sensed by the immune system: role of natural killer cell receptorsRecognition of tumors by the innate immune system and natural killer cells.Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistance.Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection.Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease.Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D LigandThe MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.NKG2D in NK and T cell-mediated immunity.Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy.4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cellsNK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligandContinuous engagement of a self-specific activation receptor induces NK cell tolerance.Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.Regulation of ligands for the activating receptor NKG2D.Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48.Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all.Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicityRegulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells
P2860
Q21131219-E3DB6FBC-B36F-43FE-AABF-FCB8D6830AA3Q24611294-68EC5A42-28E8-4549-8A34-4438CB965E58Q24635093-EA9C63D7-D0F4-4CF7-BFAC-C8513057B538Q24654966-60F62CDA-F3AF-4BDB-BCBC-0C2913B5A40DQ26797240-B7E9AAE4-E042-4715-8252-C2C0CB920D13Q27014888-17BD256A-9109-44D6-BBE8-BEAD7AFF93D8Q28533797-73EB6B1E-4F5B-4842-BFAB-C8560E72459FQ30477811-33B54D75-F007-4E16-8049-1456DB860828Q30488939-C2CC72B2-94E2-4895-AB22-2CDBC5DBD1D5Q30547087-173F11ED-621E-47DB-B614-AFF3B773C6B4Q33409763-CC6F4034-0A8C-4192-A4E7-C1678F37D0FDQ33410094-D7B63E0D-0250-4FE6-A3DF-E1814DA0FDA7Q33522918-DB27B5ED-E78A-4F59-A40E-752D8FC0FDCFQ33914699-7FC622A7-F0AB-41E6-8FAB-1D7C4E0FB140Q34062589-8E0750BD-0EF5-4A2D-A7E7-E64CCDD9FD4BQ34131549-EF331890-6BE2-4C75-9260-CD2C599BE6B5Q34132372-FD660FB1-0CE1-4B4E-8D47-EBF754DDF9D4Q34321457-2B035992-51E0-46D0-96D3-A95BC5832712Q34473267-530C3EF4-C20D-4837-9F54-775499CC3110Q34496462-48303C9A-B469-4F03-93F8-5B4B35D72ADAQ34694955-D98D4DBE-E0AC-4228-A963-B0DFE6C61A4FQ35355536-5A8FEAE8-F12A-4C33-977F-22F61FB72D56Q35531705-E4C0EE71-9942-439B-BE72-A6E431D2C620Q35541252-9472023A-FE00-407D-8E50-BDE97B67C4AFQ35826605-E6D23EC0-7F86-4844-8A19-71C71D0E57D3Q35877529-9B4D1E69-738B-4D67-9166-C5859E7D3174Q35903449-7582B431-BB02-4C0C-9BE8-5A47F09AFD82Q36210368-124B5750-B4CD-4CD7-B63B-C1283249C0E4Q36278732-6A627144-837A-4B92-99EF-0304E4390404Q36354709-06460CE3-2BBA-426D-A068-6FB5B1884BE7Q36375348-B02DE44A-AD7C-49A9-98DD-6BA521F6D61CQ36407095-6E3AF95A-11C8-4115-8F7C-573F9B0DD0BDQ36813516-CF0EFD69-42E1-4FF4-BF43-7231B14543AFQ36851896-9902F0AC-28F7-4630-AD5B-E3E24CCC6D0DQ36868340-6CDBA7F2-0976-4075-A10E-13CC380B63FFQ36872056-C2CA952F-04A6-433D-BBB4-7109E7A5E210Q36942362-E509F510-4F6A-49DB-8453-61FB66B95777Q37002810-E013A355-8522-4F1C-82BD-C57576DFC0A4Q37081973-AC7ACC29-E22C-4A5E-A607-CD760B2C850CQ37256962-6D79AFE0-0DC7-4B93-9746-9BA7573E720C
P2860
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
@en
type
label
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
@en
prefLabel
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
@en
P2093
P1476
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
@en
P2093
Alexander Steinle
Hans-Willi Mittrücker
Katrin Wiemann
Stefan A Welte
Thomas Spies
Wayne M Yokoyama
P304
P356
10.4049/JIMMUNOL.175.2.720
P407
P577
2005-07-01T00:00:00Z